HD
Hetal Dhaval Shah
About Hetal Dhaval Shah
Data last updated:
Hetal Dhaval Shah has 3 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Zydrose Pharma Private Limited and Honeymen Pharma (Opc) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Honeymen Pharma (Opc) Private Limited at ₹6.05 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Honeymen Pharma (Opc) Private Limited U24100MH2014OPC260172 | Additional Director | 25 Oct 2022 | 2014 | ₹6.05 Cr (FY 2023) | Active |
| Zydrose Pharma Private Limited U20119MH2025PTC448272 | Director | 14 May 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hetal Dhaval Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hetal Dhaval Shah
Hetal Dhaval Shah has 3 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Zydrose Pharma Private Limited and Honeymen Pharma (Opc) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Honeymen Pharma (Opc) Private Limited at ₹6.05 Cr (FY 2023).
Hetal Dhaval Shah is associated with 2 companies as Director and Additional Director, including Honeymen Pharma (Opc) Private Limited (₹6.05 Cr), Zydrose Pharma Private Limited.
Hetal Dhaval Shah has expertise in General Business.
Hetal Dhaval Shah has 3 years in corporate governance.
By reported revenue, the largest current company of Hetal Dhaval Shah is Honeymen Pharma (Opc) Private Limited, with revenue of ₹6.05 Cr (FY 2023).
Hetal Dhaval Shah currently holds positions at 2 companies: Honeymen Pharma (Opc) Private Limited (₹6.05 Cr), Zydrose Pharma Private Limited.